| __timestamp | Travere Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 59644696 | 2999000 |
| Thursday, January 1, 2015 | 79541000 | 10393000 |
| Friday, January 1, 2016 | 98015000 | 15994000 |
| Sunday, January 1, 2017 | 103958000 | 26975000 |
| Monday, January 1, 2018 | 103654000 | 39509000 |
| Tuesday, January 1, 2019 | 128951000 | 48869000 |
| Wednesday, January 1, 2020 | 135799000 | 42510000 |
| Friday, January 1, 2021 | 149883000 | 46105000 |
| Saturday, January 1, 2022 | 220206000 | 50513000 |
| Sunday, January 1, 2023 | 265542000 | 51292000 |
In pursuit of knowledge
In the dynamic world of biotechnology, effective cost management is crucial for sustaining innovation and growth. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent biotech companies: Travere Therapeutics, Inc. and Wave Life Sciences Ltd., from 2014 to 2023.
Travere Therapeutics has seen a significant rise in SG&A expenses, increasing by approximately 345% over the decade, peaking at $266 million in 2023. This upward trend reflects the company's aggressive expansion and investment in administrative capabilities. In contrast, Wave Life Sciences Ltd. has maintained a more conservative growth in SG&A expenses, with a 1,610% increase, reaching $51 million in 2023. This suggests a strategic focus on streamlined operations while still supporting their innovative pipeline.
Understanding these trends provides valuable insights into how these companies balance operational costs with their strategic objectives.
Neurocrine Biosciences, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Incyte Corporation or Travere Therapeutics, Inc.
Comparing SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Wave Life Sciences Ltd. Trends and Insights
Operational Costs Compared: SG&A Analysis of Veracyte, Inc. and Travere Therapeutics, Inc.
Who Optimizes SG&A Costs Better? MorphoSys AG or Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Catalyst Pharmaceuticals, Inc. or Wave Life Sciences Ltd.
HUTCHMED (China) Limited or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Wave Life Sciences Ltd.
Who Optimizes SG&A Costs Better? Geron Corporation or Wave Life Sciences Ltd.
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Wave Life Sciences Ltd. and Novavax, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.